|
市場調査レポート
商品コード
1701097
ライフサイエンス分析の市場規模、シェア、成長分析、コンポーネント別、タイプ別、アプリケーション別、デリバリーモード別、エンドユーザー別、地域別 - 産業予測 2025-2032年Life Science Analytics Market Size, Share, and Growth Analysis, By Component (Software, Services), By Type (Descriptive Analytics, Predictive Analytics), By Application, By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032 |
||||||
|
|||||||
| ライフサイエンス分析の市場規模、シェア、成長分析、コンポーネント別、タイプ別、アプリケーション別、デリバリーモード別、エンドユーザー別、地域別 - 産業予測 2025-2032年 |
|
出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
ライフサイエンス分析市場規模は、2023年に298億6,000万米ドルと評価され、2024年の332億6,000万米ドルから2032年には780億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.4％で成長する見通しです。
ライフサイエンス分析市場は、電子カルテ、臨床試験、ゲノムシーケンス、ウェアラブル、ソーシャルメディアなど多様なソースから生成されるヘルスケアデータ量の急増に後押しされ、大幅な成長が見込まれています。データのプライバシーや統合といった課題に直面しているもの、この分野は、特に創薬と個別化医療を強化するための人工知能（AI）と機械学習（ML）の統合を通じて、顕著な機会を提示しています。ライフサイエンス分野では、エビデンスに基づく意思決定が世界的に求められており、この動向はさらに加速しています。開発企業はアナリティクスを活用することで、医薬品開発におけるイノベーションを推進し、患者ケアを向上させ、業務効率を改善し、利用可能な豊富なヘルスケアデータを活用することで、急速に進化する状況の中で戦略的なポジショニングをとることができます。
目次
イントロダクション
- 調査の目的
- 調査範囲
- 定義
調査手法
- 情報調達
- 二次と一次データの方法
- 市場規模予測
- 市場の前提条件と制限
エグゼクティブサマリー
- 世界市場の見通し
- 供給と需要の動向分析
- セグメント別機会分析
市場力学と見通し
- 市場概要
- 市場規模
- 市場力学
- 促進要因と機会
- 抑制要因と課題
- ポーターの分析
主な市場の考察
- 重要成功要因
- 競合の程度
- 主な投資機会
- 市場エコシステム
- 市場の魅力指数（2024年）
- PESTEL分析
- マクロ経済指標
- バリューチェーン分析
- 価格分析
- ケーススタディ
- 技術の進歩
- 規制情勢
ライフサイエンス分析市場規模：コンポーネント別& CAGR（2025-2032）
- 市場概要
- ソフトウェア
- オンプレミスソリューション
- クラウドベースのソリューション
- SAASベースのソリューション
- サービス
- マネージドサービス
- 分析サービス
- コンサルティングサービス
- プロフェッショナルサービス
- トレーニングと実装
- メンテナンスおよびサポートサービス
- その他
ライフサイエンス分析市場規模：タイプ別& CAGR（2025-2032）
- 市場概要
- 記述的分析
- 予測分析
- 処方的分析
ライフサイエンス分析市場規模：アプリケーション別& CAGR（2025-2032）
- 市場概要
- 研究開発
- 臨床試験
- 前臨床および創薬
- 商業分析
- セールス＆マーケティングサポート
- 市場アクセス
- RWEと価値証拠
- エンゲージメントサービス
- 規制コンプライアンス
- 製造およびサプライチェーンの最適化
- 安全性
- 医薬品安全性監視
- 医療機器の安全性
- 診断警戒
ライフサイエンス分析市場規模：デリバリーモード別& CAGR（2025-2032）
- 市場概要
- オンプレミス
- クラウドベース
ライフサイエンス分析市場規模：エンドユーザー別& CAGR（2025-2032）
- 市場概要
- 製薬およびバイオテクノロジー企業
- 医療機器企業
- 研究センター
- サードパーティ管理者
- その他
ライフサイエンス分析市場規模：地域別& CAGR（2025-2032）
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
- アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情報
- 上位5社の比較
- 主要企業の市場ポジショニング（2024年）
- 主な市場企業が採用した戦略
- 最近の市場動向
- 企業の市場シェア分析（2024年）
- 主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）
主要企業プロファイル
- Accenture（Ireland）
- Cognizant（USA）
- IBM Corporation（USA）
- MaxisIT（USA）
- Oracle Corporation（USA）
- IQVIA（USA）
- SAS Institute Inc.（USA）
- EXL Service（Scioinspire Corp.）（USA）
- Take Solutions Limited（India）
- Wipro Limited（India）
- Dynata（USA）
- M3（EU）Ltd（UK）
- Serma Group（France）
- Apollo Intelligence（USA）
- Allscripts Healthcare Solutions（USA）
- Cerner Corporation（USA）
- Optum（USA）
- Microsoft（USA）
- Infosys Limited（India）
結論と提言
Life Science Analytics Market size was valued at USD 29.86 Billion in 2023 and is poised to grow from USD 33.26 Billion in 2024 to USD 78.09 Billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).
The life science analytics market is poised for substantial growth, propelled by the escalating volume of healthcare data generated from diverse sources like electronic health records, clinical trials, genomic sequencing, wearables, and social media. Despite facing challenges such as data privacy and integration, the sector presents remarkable opportunities, particularly through the integration of artificial intelligence (AI) and machine learning (ML) to enhance drug discovery and personalized medicine. The global demand for evidence-based decision-making in life sciences further fuels this trend. Organizations can harness analytics to drive innovation in drug development, elevate patient care, and improve operational efficiency, positioning themselves strategically in this rapidly evolving landscape by leveraging the wealth of healthcare data available.
Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Life Science Analytics Market Segments Analysis
The global life science analytics market is segmented based on type, component, delivery, application, end-user and region. Based on type, the market is segmented into descriptive, predictive, and prescriptive. Based on component, the market is segmented into software, and services. In terms of delivery, the market is segmented into on-premise model, and on-demand model. Based on application, the market is segmented into research & development, preclinical trials, clinical trials, sales & marketing, regulatory compliance, supply chain optimization, pharmacovigilance. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Driver of the Life Science Analytics Market
The increasing use of real-world data, such as electronic health records, wearable devices, and social media interactions, is significantly fueling the demand for analytics solutions in the Life Science Analytics market. This type of data offers critical insights into patient outcomes, the effectiveness of treatments, and overall population health trends. By leveraging these insights, stakeholders in the life sciences industry can make informed, evidence-based decisions that enhance patient care and optimize health outcomes. The shift towards data-driven approaches is thus pivotal in transforming the landscape of life sciences, prompting a growing need for advanced analytics capabilities.
Restraints in the Life Science Analytics Market
The Life Science Analytics market faces significant challenges due to the handling of sensitive patient information, which raises critical issues surrounding data privacy and security. Stringent regulations and compliance mandates, such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), complicate data governance for organizations. Navigating these legal frameworks is essential to ensure the protection of patient confidentiality, but it can also create logistical hurdles and increased operational costs. As companies strive to adhere to these regulations, they may encounter difficulties that hamper innovation and slow down the overall growth of the market.
Market Trends of the Life Science Analytics Market
The Life Science Analytics market is experiencing a pronounced trend towards real-time analytics, significantly transforming decision-making processes within the industry. As organizations strive for agility in an increasingly dynamic environment, the demand for real-time data integration, processing, and analysis is intensifying. This shift is particularly evident in sectors like personalized medicine, where timely insights can enhance treatment outcomes, and in patient monitoring, which necessitates immediate data-driven responses. Furthermore, supply chain optimization is being revolutionized by real-time insights, allowing firms to adapt swiftly to fluctuations in demand and improve operational efficiency. Thus, the ability to harness real-time analytics is becoming a critical competitive differentiator in the life sciences landscape.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Technology Advancement
- Regulatory Landscape
Global Life Science Analytics Market Size by Component & CAGR (2025-2032)
- Market Overview
- Software
- On-Premise Solutions
- Cloud-Based Solutions
- SAAS-Based Solutions
- Services
- Managed Services
- Analytical Services
- Consulting Services
- Professional Services
- Training & Implementation
- Maintenance & Support Services
- Other
Global Life Science Analytics Market Size by Type & CAGR (2025-2032)
- Market Overview
- Descriptive Analytics
- Predictive Analytics
- Prescriptive Analytics
Global Life Science Analytics Market Size by Application & CAGR (2025-2032)
- Market Overview
- Research and Development
- Clinical Trials
- Preclinical & Drug Discovery
- Commercial Analytics
- Sales & Marketing Support
- Market Access
- RWE & Value Evidence
- Engagement Services
- Regulatory Compliance
- Manufacturing & Supply Chain Optimization
- Safety
- Pharmacovigilance
- Medical Device Safety
- Diagnostic Vigilance
Global Life Science Analytics Market Size by Delivery Mode & CAGR (2025-2032)
- Market Overview
- On-Premises
- Cloud-Based
Global Life Science Analytics Market Size by End-User & CAGR (2025-2032)
- Market Overview
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Research Centers
- Third-Party Administrators
- Others
Global Life Science Analytics Market Size & CAGR (2025-2032)
- North America (Component, Type, Application, Delivery Mode, End-User)
- US
- Canada
- Europe (Component, Type, Application, Delivery Mode, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Component, Type, Application, Delivery Mode, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Component, Type, Application, Delivery Mode, End-User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Component, Type, Application, Delivery Mode, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Accenture (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cognizant (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IBM Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MaxisIT (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oracle Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IQVIA (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SAS Institute Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EXL Service (Scioinspire Corp.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Take Solutions Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wipro Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dynata (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- M3 (EU) Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Serma Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Apollo Intelligence (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allscripts Healthcare Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cerner Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Optum (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microsoft (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Infosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
